+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID02752542

Personalized Treatment Using Cognitive Behavioral Therapy or Antidepressants for Adults with Major or Persistent Depressive Disorder

Led by Nova Scotia Health Authority · Updated on 2025-05-14

80

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Depression is a common and disabling condition affecting millions worldwide, including nearly 2 million Canadians. This research aims to improve treatment by studying how specific clinical factors and biomarkers can predict whether an individual will respond better to antidepressant medication or cognitive-behavioral therapy CBT. The study focuses on adults diagnosed with major depressive disorder or persistent depressive disorder, exploring personalized treatment choices to enhance outcomes and healthcare efficiency. Participants will be randomly assigned to receive either CBT or antidepressant medication. CBT involves up to 20 one-on-one sessions over 18 weeks, starting twice weekly and gradually spacing out, delivered by trained therapists following a structured protocol. Pharmacotherapy includes psychiatrist-prescribed antidepressants, mainly serotonin-reuptake inhibitors like escitalopram or sertraline, with possible augmentation if needed. Medication sessions occur every two weeks and follow established clinical guidelines. During the study, participants will undergo regular assessments using depression rating scales such as the Montgomery Asberg Depression Rating Scale over 2 to 52 weeks. Researchers will monitor symptom changes, treatment response, and safety throughout. The study will also collect data on clinical predictors and biomarkers to evaluate their ability to guide personalized treatment selection. Total participation lasts up to one year, with ongoing evaluations to refine treatment algorithms and improve care for depression.

CONDITIONS

Brief Title

Personalized Indications for CBT and Antidepressants in Treating Depression

Research Team

R

Rudolf Uher, MD, PhD

J

Jill Cumby, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here